Alzheimer’s Research Center is committed to quality care for all of our patients. Patients that are enrolled in our research studies have access to the latest in Alzheimer’s therapies in a setting where patients can feel comfortable and connected. Your safety and satisfaction is our primary concern. We work closely with patients and caregivers in order to provide unique programs that are on the cutting edge of cognitive innovation, all of which are compliant with FDA guidelines.
The staff at Alzheimer’s Research Center have all dedicated themselves to working with Alzheimer’s patients. This dedication and passion along with the combined knowledge of all of our doctors results in unrivaled care for all of the NAA’s patients.
The Benefits of our Patients
- Patients have access to the most innovative treatments
- Examination and treatment by experts in the field of Alzheimer’s and other dementias
- Initial assessment, memory testing, and examination
- Access to the latest medications
- Treatment with latest studies under FDA guidelines
Dr. Richard Holub is president of Alzheimer’s Research Center an organization that consists of a highly respected research professionals providing a full complement of clinical research services.
Dr. Holub has been conducting phase II and Phase III clinical trials for over 35 years. During his impressive career, Dr. Holub has conducted over 134 successful clinical trials and has played a significant role in the investigation of all five drugs currently approved by the FDA for the Treatment of Alzheimer’s Disease.
Alzheimer’s Research Center encompasses over 6,000 square feet of space and houses experienced research coordinators, psychometricians, a physician assistant as well as lab and support personnel. The office has a fully functioning lab, an infusion suite, and cognitive testing rooms. Alzheimer’s Research Center also has long standing professional relationships with a number of local imaging centers which allows it to conduct all of the activities that are a typical part of any standard clinical trial.
Since Alzheimer’s Research Center staff prescreens every patient, the division’s screen failure rate is very low. Alzheimer’s Research Center is noted for our ability to recruit high numbers of eligible patients and associated high retention rates.
Our clinic is one of the leading centers in New York State conducting clinical trials. Talk with us! Get involved today.
Why Clinical Trials for Alzheimer’s Are Necessary
What a great world it would be if we knew how to prevent, or even cure, all types of cognitive impairment disorders.
Medical providers do all they can with conventional therapies, but to treat Alzheimer’s long term, we must also incorporate innovative therapies beyond the standard of care.
Since nearly all of today’s Alzheimer’s treatments began with breakthrough discoveries emanating from clinical trials, providing Alzheimer’s patients with access to these trials can significantly improve their prospects and is, therefore, a crucial component of a comprehensive Alzheimer’s care program.
Whether patients receive a placebo or the therapy being tested, they are likely to perform better than patients receiving conventional care because of the extra attention they get.
As part of the trial protocol, clinical trial patients are seen more frequently, receive regular extensive evaluations, and in the case of patients involved in clinical trials are repeatedly evaluated for several years to measure the effectiveness of the tested therapy.
There’s a psychological benefit, too; just knowing they are part of a clinical trial improves the mental outlook of patients struggling with serious illness.
The community also gains something when a local institution/clinic engages in clinical trials. The best and the brightest minds in medicine are drawn to institutions/clinics where they can conduct clinical research; their skill and knowledge benefit all patients, not just those participating in clinical trials.
Contact Us to get involved in Alzheimer’s Disease clinical research today!
If you or a loved one has been diagnosed with Alzheimer’s or have experienced noticeable memory loss, you should know about our study evaluating a drug aimed at halting the progression of mild Alzheimer’s.
Participants in this study will receive study-related care from a team of medical professionals, study-related exams, and the study drug after the clinical trial is complete, all at no cost.
If you are interested to see if you pre-qualify for this study, please take our pre-screener. You will be asked a series of questions about either your Alzheimer’s or answering on behalf of the person with Alzheimer’s for whom you are caring. The information you provide will not be shared without your consent.